Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changchun Xinan Pharmaceutical Group is a Chinese pharmaceutical company specializing in the development, manufacture, and distribution of plant-based and traditional Chinese medicine (TCM) products. Founded in 2002 and based in Changchun, Jilin Province, the company primarily serves the rural healthcare market with a portfolio of over 100 products, including treatments for bone spurs, gingivitis, and various health supplements. In 2007, it was acquired by American Oriental Bioengineering (AOBO) to expand its product offerings and distribution network in China. The company operates manufacturing facilities and focuses on providing affordable healthcare solutions, with many of its products covered under government insurance plans.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changchun Xinan Pharmaceutical Group.